Cargando…

Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection

The COVID-19 pandemic caused by the SARS-CoV-2 virus made it necessary to search for new options for both causal treatment and mitigation of its symptoms. Scientists and researchers around the world are constantly looking for the best therapeutic options. These difficult circumstances have also spur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janecki, Marcin, Graczyk, Michał, Lewandowska, Agata Anna, Pawlak, Łukasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025270/ https://www.ncbi.nlm.nih.gov/pubmed/35456990 http://dx.doi.org/10.3390/ijms23084170

Ejemplares similares

Relationship between breakthrough cancer pain, background cancer pain and analgesic treatment – case series and review of the literature
por: Batistaki, Chrysanthi, et al.
Publicado: (2022)

Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series
por: Graczyk, Michał, et al.
Publicado: (2022)

Prospects for the Use of Cannabinoids in Psychiatric Disorders
por: Graczyk, Michał, et al.
Publicado: (2021)

Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids and Cannabis sativa: A Comprehensive Review
por: Mahmud, Md Sultan, et al.
Publicado: (2021)

Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches
por: Raj, Vinit, et al.
Publicado: (2021)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation
por: Graczyk, Michał, et al.
Publicado: (2021)

Antiviral activities of hemp cannabinoids
por: van Breemen, Richard B., et al.
Publicado: (2023)

The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection
por: Shahzad, Fanila, et al.
Publicado: (2020)

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
por: Péricat, David, et al.
Publicado: (2022)

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
por: Péricat, D., et al.
Publicado: (2023)

Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
por: ONAY, Ahmet, et al.
Publicado: (2021)

SARS-CoV-2: Outline, Prevention, and Decontamination
por: Janik, Edyta, et al.
Publicado: (2021)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms
por: Malebari, Azizah M., et al.
Publicado: (2023)

Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections
por: Xie, Peifang, et al.
Publicado: (2021)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
por: Kukla, Michał, et al.
Publicado: (2021)

Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
por: Lv, Zongyang, et al.
Publicado: (2022)

Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia
por: Niemeyer, Brian F., et al.
Publicado: (2021)

Cannabinoid-like anti-inflammatory compounds from flax fiber
por: Styrczewska, Monika, et al.
Publicado: (2012)

Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition
por: Sanna, Vanna, et al.
Publicado: (2022)

Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404
por: Fàbrega-Ferrer, Montserrat, et al.
Publicado: (2022)

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
por: Byrareddy, Siddappa N., et al.
Publicado: (2020)

Antiviral Immunoglobulins of Chicken Egg Yolk for Potential Prevention of SARS-CoV-2 Infection
por: Ravlo, Erlend, et al.
Publicado: (2022)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Antiviral zinc oxide nanoparticles mediated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2
por: Attia, Gouda H., et al.
Publicado: (2021)

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
por: Rossi, Francesca, et al.
Publicado: (2020)

SARS-CoV-2 and Cytomegalovirus Coinfection in a Patient With Myocarditis and Severe COVID-19 Infection
por: Pawlak, Agnieszka, et al.
Publicado: (2023)

Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2
por: Stefanik, Michal, et al.
Publicado: (2021)

Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review
por: Frediansyah, Andri, et al.
Publicado: (2022)

Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
por: Creeden, Justin Fortune, et al.
Publicado: (2021)

Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases
por: Homaeigohar, Shahin, et al.
Publicado: (2023)

Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
por: Fratta Pasini, Anna M., et al.
Publicado: (2021)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
por: Rebeaud, Mathieu E., et al.
Publicado: (2020)

Host proviral and antiviral factors for SARS-CoV-2
por: Lv, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jlnb18g2uduv0at505cppuveq3